Carlos Diaz-Arocutipa
Overview
Explore the profile of Carlos Diaz-Arocutipa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diaz-Arocutipa C, Benites-Moya C, Torres-Valencia J, Mehta A, Vicent L
Clin Cardiol
. 2025 Mar;
48(3):e70067.
PMID: 40063420
Background: To assess in-hospital outcomes in patients undergoing urgent versus non-urgent transcatheter mitral edge-to-edge repair (TEER). Methods: We used the NIS database 2016-2019 to include admissions who underwent TEER. Inverse...
2.
Diaz-Arocutipa C, Chumbiauca M, Soto-Becerra P
Am J Trop Med Hyg
. 2025 Feb;
PMID: 39933179
There is uncertainty regarding the usefulness of predictive models for dengue prognosis. We performed a systematic review to identify and evaluate prognostic models in patients with dengue. We conducted a...
3.
Diaz-Arocutipa C, Vargas-Rivas C, Mendoza-Quispe D, Benites-Moya C, Torres-Valencia J, Valenzuela-Rodriguez G, et al.
CJC Open
. 2025 Jan;
7(1):78-87.
PMID: 39872642
Background: Primary percutaneous coronary intervention (PCI) is the established treatment for ST-segment elevation myocardial infarction (STEMI), but often it is not readily available in low-resource settings. We assessed the safety...
4.
Torres-Valencia J, Zavaleta-Camacho G, Saucedo-Chinchay J, Alayo-Rojas K, Diaz-Arocutipa C
Arch Peru Cardiol Cir Cardiovasc
. 2025 Jan;
5(4):249-254.
PMID: 39850343
Peripartum cardiomyopathy (PPCM) is a potentially life-threatening condition that can occur during the late pregnancy or puerperium. A 31-year-old woman with a recent twin pregnancy presented with heart failure symptoms...
5.
Diaz-Arocutipa C, Salguero-Bodes R, Juarez V, Martin-Asenjo R, Valenzuela-Rodriguez G, Torres-Valencia J, et al.
Curr Probl Cardiol
. 2025 Jan;
50(3):102985.
PMID: 39828110
Background: Heart failure (HF) represents a significant public health challenge, particularly in low- and middle-income countries, where demographic shifts and healthcare disparities influence disease patterns. This study aimed to analyze...
6.
Diaz-Arocutipa C, Hernandez A
Clin Cardiol
. 2025 Jan;
48(1):e70054.
PMID: 39817430
Background: There is scarce data on the prognostic value of frailty in patients with Takotsubo cardiomyopathy (TCM). This study aimed to assess the association between frailty and in-hospital outcomes in...
7.
Diaz-Arocutipa C, Hernandez A, Benites-Moya C, Gamarra-Valverde N, Yrivarren-Cespedes R, Torres-Valencia J, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39809594
Aims: Differentiation between patients with Takotsubo syndrome and acute coronary syndrome (ACS) remains a challenge. We performed a systematic review to identify and evaluate diagnostic predictive models to distinguish both...
8.
Diaz-Arocutipa C, Benites-Moya C, Apple S, Vallabhajosyula S
Cardiovasc Revasc Med
. 2025 Jan;
PMID: 39755528
Background: There is uncertainty about the use of the CHA2DS2-VASc score to predict clinical events in patients with Takotsubo syndrome (TTS). This study aimed to assess the short-term prognostic role...
9.
Diaz-Arocutipa C, Bueno H, Moreno G, Olmos V, Vicent L
Shock
. 2024 Dec;
63(1):36-42.
PMID: 39671550
Background: Our study aims to compare in-hospital management and outcomes in patients with cardiogenic shock due to ST-segment elevation myocardial infarction (STEMI) versus non-ST-segment elevation myocardial infarction (NSTEMI). Methods: We...
10.
Diaz-Arocutipa C, Moreno G, Giraldez M, Hernandez A, Mamas M, Vicent L
CJC Open
. 2024 Nov;
6(9):1108-1115.
PMID: 39525820
Background: Data are limited that examine potential sex-based disparities in the utilization and complications of septal reduction therapy (SRT) in patients with obstructive hypertrophic cardiomyopathy. Our aim was to assess...